These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New insights and approaches to reduce end-organ damage in the treatment of hypertension: subsets of hypertension approach. Houston MC Am Heart J; 1992 May; 123(5):1337-67. PubMed ID: 1575152 [TBL] [Abstract][Full Text] [Related]
4. Hypertension and the kidney. Wesson DE Curr Hypertens Rep; 2001 Dec; 3(6):511-6. PubMed ID: 11734098 [TBL] [Abstract][Full Text] [Related]
5. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Wong TY; McIntosh R Br Med Bull; 2005; 73-74():57-70. PubMed ID: 16148191 [TBL] [Abstract][Full Text] [Related]
6. High blood pressure and end-organ damage. Cutler JA J Hypertens Suppl; 1996 Dec; 14(6):S3-6. PubMed ID: 9023707 [TBL] [Abstract][Full Text] [Related]
7. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. He J; Whelton PK J Hypertens Suppl; 1999 Jun; 17(2):S7-13. PubMed ID: 10465061 [TBL] [Abstract][Full Text] [Related]
8. The hypertensive diseases. Evidence that systemic hypertension is a greater risk factor to the development of other cardiovascular diseases than previously suspected. Roberts WC Am J Med; 1975 Oct; 59(4):523-32. PubMed ID: 126644 [TBL] [Abstract][Full Text] [Related]
9. [Epidemiology of arterial hypertension and organ damage]. Licata G Ann Ital Med Int; 1994 Oct; 9 Suppl():44S-49S. PubMed ID: 7857756 [TBL] [Abstract][Full Text] [Related]
10. Hypertensive emergencies. Moore MA Am Fam Physician; 1980 Mar; 21(3):141-6. PubMed ID: 7355684 [TBL] [Abstract][Full Text] [Related]
11. Current hypertension control is just not good enough. Dustan HP Am Fam Physician; 1998 Oct; 58(6):1292, 1295-6. PubMed ID: 9803188 [No Abstract] [Full Text] [Related]
12. Classic papers symposium: ambulatory blood pressure monitoring and hypertensive target organ damage. DiPette DJ; Townsend RR Am J Med Sci; 1996 Nov; 312(5):221-4. PubMed ID: 8900385 [TBL] [Abstract][Full Text] [Related]
13. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat? Rosansky SJ Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957 [TBL] [Abstract][Full Text] [Related]
14. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Sim JJ; Bhandari SK; Shi J; Reynolds K; Calhoun DA; Kalantar-Zadeh K; Jacobsen SJ Kidney Int; 2015 Sep; 88(3):622-32. PubMed ID: 25945406 [TBL] [Abstract][Full Text] [Related]
15. Cardiac effects of chronic renal failure and haemodialysis treatment. Hypertensive versus normotensive patients. Ikäheimo M; Huttunen K; Takkunen J Br Heart J; 1981 Jun; 45(6):710-6. PubMed ID: 7259920 [No Abstract] [Full Text] [Related]
17. Role of hypertension in atherosclerosis and cardiovascular disease. Hollander W Am J Cardiol; 1976 Nov; 38(6):786-800. PubMed ID: 136891 [TBL] [Abstract][Full Text] [Related]
18. Drug therapy. IV. The treatment of hypertension with complications. Aagaard GN Northwest Med; 1970 Mar; 69(3):167-9. PubMed ID: 5417751 [No Abstract] [Full Text] [Related]
19. Role of hypertension in ischemic heart disease and cerebral vascular disease in the cynomolgus monkey with coarctation of the aorta. Hollander W; Prusty S; Kirkpatrick B; Paddock J; Nagraj S Circ Res; 1977 May; 40(5 Suppl 1):I70-83. PubMed ID: 140028 [TBL] [Abstract][Full Text] [Related]
20. A call to action for more aggressive treatment of hypertension. Lenfant C; Roccella EJ J Hypertens Suppl; 1999 Feb; 17(1):S3-7. PubMed ID: 10340837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]